Velentium vs Zühlke: full comparison for 2026
Quick verdict
Velentium (4.5/5) edges ahead of Zühlke (4.4/5) overall. Velentium is the better choice for implantables and FDA cybersecurity submissions. Zühlke is the stronger option for european medtech firms modernizing device software. The right choice depends on your project size, budget, and required tech stack.
Velentium vs Zühlke: head-to-head summary
| Criterion | Velentium | Zühlke |
|---|---|---|
| Founded | 2012 | 1968 |
| HQ | Katy, TX, USA | Schlieren, Switzerland |
| Team size | 51–250 | 1,500–2,000 |
| Rating | 4.5 / 5 | 4.4 / 5 |
| Primary differentiator | Combines active-implantable engineering with a dedicated device cybersecurity team that prepares FDA premarket security documentation | A device engineering practice and a large digital practice under one owner, useful when a device program is really a platform program |
| Pricing model | Fixed project, time and materials, manufacturing contract | Time and materials, fixed project |
| Min. engagement | Not disclosed | Not disclosed |
| Primary tech stack | Embedded C/C++, RTOS, BLE | Embedded C/C++, Embedded Linux, Cloud (AWS/Azure) |
| Industries served | Implantables & neuromodulation, Surgical & therapeutic devices, Wearables & remote monitoring | Digital health, Diagnostics & lab devices, Surgical & therapeutic devices, Financial services |
Velentium vs Zühlke: overview
Velentium
Velentium was founded in 2012 and is based in Katy, near Houston, Texas. It designs, develops and manufactures active medical devices, including implantables and their programmers, and offers systems engineering, firmware, software, cybersecurity and CGMP manufacturing. Great Point Partners completed a growth recapitalization in 2021, the company sold its oil and gas division in 2023 to focus fully on medtech, and it took $15M in growth financing from Trinity Capital in 2024. Headcount estimates range from 51 to 250.
Zühlke
Partner-owned since its 1968 founding in Switzerland, Zühlke is headquartered in Schlieren near Zurich, with teams in Germany, Austria, the UK, Serbia and Asia. Its headcount is somewhere between 1,500 and 2,000 depending on the source. In healthcare it covers regulated device and systems engineering, connected-device software and the cloud and analytics platforms around devices, and it states more than 50 years of medtech experience (per company website; independently unverifiable).
Services and capabilities: Velentium vs Zühlke
| Capability | Velentium | Zühlke |
|---|---|---|
| Electronics & PCB design | ✓ | ✓ |
| Firmware & embedded software | ✓ | ✓ |
| SaMD & companion apps | ✗ | ✓ |
| Connected devices & IoT | ✗ | ✓ |
| Industrial design & human factors | ✗ | ✗ |
| Mechanical engineering | ✗ | ✗ |
| Device cybersecurity | ✓ | ✗ |
| Regulatory & QMS support | ✓ | ✓ |
| Manufacturing & scale-up | ✓ | ✗ |
Tech stack comparison: Velentium vs Zühlke
| Framework / platform | Velentium | Zühlke |
|---|---|---|
| Embedded C/C++ | ✓ | ✓ |
| Embedded Linux | N/A | ✓ |
| RTOS | ✓ | N/A |
| BLE | ✓ | N/A |
| Cloud (AWS/Azure) | N/A | ✓ |
| IEC 62304 | ✓ | ✓ |
| ISO 14971 | ✓ | N/A |
| ISO 13485 QMS | N/A | N/A |
| Qt | N/A | ✓ |
Pricing comparison: Velentium vs Zühlke
| Criterion | Velentium | Zühlke |
|---|---|---|
| Minimum engagement | Not disclosed | Not disclosed |
| Engagement models | Fixed project, Manufacturing contract, Time & materials | Consulting, Dedicated team, Fixed project, Time & materials |
| Rate transparency | Not public | Not public |
| Price tier | Mid-market | Mid-market |
Target audience comparison: Velentium vs Zühlke
| Dimension | Velentium | Zühlke |
|---|---|---|
| Best company size | Startup to mid-market | Startup to mid-market |
| Best industries | Implantables & neuromodulation, Surgical & therapeutic devices, Wearables & remote monitoring | Digital health, Diagnostics & lab devices, Surgical & therapeutic devices |
| Best use cases | Building a neurostimulator and its clinician programmer, Preparing the cybersecurity section of an FDA 510(k) or PMA | Rebuilding the embedded and cloud software of an established diagnostics platform, EU MDR remediation of legacy device software |
| Typical project type | Fixed project | Consulting |
Velentium vs Zühlke: pros and cons
| Velentium | |
|---|---|
| + | Cybersecurity is a full practice here, covering threat modeling, SBOMs, testing and postmarket monitoring |
| + | Experience with active implantable devices, one of the hardest device categories to engineer and certify |
| + | Can manufacture Class II and III devices after development, reducing transfer risk |
| + | Offers training on device cybersecurity, which helps client teams keep up after hand-off |
| - | Private-equity recapitalization and debt financing mean ownership priorities may shift over time |
| - | Smaller than the large consultancies, so very broad programs may stretch the team |
| - | Industrial design and human factors are not its main strength |
| Zühlke | |
|---|---|
| + | Partner ownership keeps the firm independent of a large holding group |
| + | Large enough to staff hardware, embedded, cloud and data roles at the same time |
| + | Delivery centres in Serbia and Asia give some cost flexibility compared with all-Swiss teams |
| + | Experience with EU MDR environments in German-speaking markets |
| - | Much of the firm works outside healthcare, so check that the proposed team is from the medtech practice |
| - | Swiss and German rates are high for the onshore part of a team |
| - | Industrial design and manufacturing are not core offerings |
Who should choose Velentium?
A typical fit: building a neurostimulator and its clinician programmer.
Combines active-implantable engineering with a dedicated device cybersecurity team that prepares FDA premarket security documentation. Minimum engagement is not publicly disclosed. Works best with clients in Implantables & neuromodulation, Surgical & therapeutic devices, Wearables & remote monitoring.
Who should choose Zühlke?
A typical fit: rebuilding the embedded and cloud software of an established diagnostics platform.
A device engineering practice and a large digital practice under one owner, useful when a device program is really a platform program. Minimum engagement is not publicly disclosed. Works best with clients in Digital health, Diagnostics & lab devices, Surgical & therapeutic devices, Financial services.
Decision matrix: Velentium vs Zühlke
| Your situation | Recommended choice |
|---|---|
| You need full-ownership delivery on a defined project scope | Velentium |
| You need a large dedicated team for an ongoing programme | Zühlke |
| Your budget is at the lower end | Compare: Velentium (Not disclosed) vs Zühlke (Not disclosed) |
| You need specialist depth in a specific vertical | Zühlke |
| You need staff augmentation or team extension | Neither; consider alternatives that offer staff aug |
| You need consulting before committing to a build | Both may offer discovery engagements |
Use case fit: Velentium vs Zühlke
| Use case | Velentium fit | Zühlke fit | Winner |
|---|---|---|---|
| Building a neurostimulator and its clinician programmer | Strong | Strong | Both equally |
| Preparing the cybersecurity section of an FDA 510(k) or PMA | Strong | Limited | Velentium |
| Rebuilding the embedded and cloud software of an established diagnostics platform | Limited | Strong | Zühlke |
| EU MDR remediation of legacy device software | Strong | Strong | Both equally |
Verdict: Velentium vs Zühlke
Velentium (4.5/5) is the stronger overall choice for most Medical Device Development projects. Combines active-implantable engineering with a dedicated device cybersecurity team that prepares FDA premarket security documentation.
Zühlke (4.4/5) is worth a look if you need EU MDR remediation of legacy device software. If your situation matches that, Zühlke is a competitive option.
Related comparisons
Velentium vs Zühlke FAQ
Is Velentium better than Zühlke?
Velentium (4.5/5) scores higher overall, but "better" depends on your use case. Velentium's strongest advantage: cybersecurity is a full practice here, covering threat modeling, SBOMs, testing and postmarket monitoring. Zühlke's strongest advantage: partner ownership keeps the firm independent of a large holding group.
How do Velentium and Zühlke differ in pricing?
Velentium uses fixed project, time and materials, manufacturing contract pricing. Zühlke uses time and materials, fixed project pricing. Neither firm publishes a full rate card; a discovery call is required for project-specific quotes.
Which is better for enterprise: Velentium or Zühlke?
Zühlke is the larger team and typically the better enterprise-scale choice. For very large programmes, verify team size and compliance coverage directly with each company before shortlisting.
What are the main differences between Velentium and Zühlke?
Velentium's primary differentiator is: combines active-implantable engineering with a dedicated device cybersecurity team that prepares FDA premarket security documentation. Zühlke's primary differentiator is: a device engineering practice and a large digital practice under one owner, useful when a device program is really a platform program. They also differ in team size (51–250 vs 1,500–2,000), minimum engagement (Not disclosed vs Not disclosed), and primary industries served (Implantables & neuromodulation, Surgical & therapeutic devices vs Digital health, Diagnostics & lab devices).
Verify all details directly with each company before making a decision.